Coty (COTY)
(Delayed Data from NYSE)
$9.63 USD
+0.21 (2.23%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $9.62 -0.01 (-0.10%) 5:18 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.63 USD
+0.21 (2.23%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $9.62 -0.01 (-0.10%) 5:18 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
Is Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.
Mondelez (MDLZ) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2023 performance is likely to gain from effective pricing actions and prudent buyouts. Strength in the company's snacking category is an upside.
Is a Beat in Store for Church & Dwight (CHD) in Q2 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter results are likely to reflect gains from pricing, innovation and demand amid elevated costs.
The Hershey Company (HSY) Queues for Q2 Earnings: What Awaits?
by Zacks Equity Research
The Hershey Company's (HSY) second-quarter results are likely to reflect gains from pricing and innovation. Prudent buyouts have also been a driver.
Pilgrim's Pride (PPC) Queues for Q2 Earnings: What's in Store?
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter results are likely to reflect the impacts of cost inflation, while customer-centric initiatives and solid foodservice demand bode well.
Lamb Weston (LW) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2023 performance is likely to reflect gains from expansion efforts and effective pricing actions.
Is a Beat in Store for Kimberly-Clark (KMB) in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter results are likely to reflect gains from revenue management efforts and strategic growth pillars amid cost inflation.
COTY Inks Agreement to Offload 3.6% of Its Stake in Wella
by Zacks Equity Research
COTY inks a letter of intent to divest part of its stake in Wella to IGF Wealth Management. This is likely to help the company meet its leverage goal toward 3X as it exits CY23.
5 Top Stocks Likely to Exceed Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Coty (COTY), BJ's Restaurants (BJRI), Palo Alto Networks (PANW), Livent (LTHM) and Bath & Body Works (BBWI).
Philip Morris (PM) Readies for Q2 Earnings: Things to Note
by Zacks Equity Research
Philip Morris' (PM) second-quarter results are likely to reflect gains from pricing and strength in reduced-risk products amid cost inflation.
COTY or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
COTY vs. EL: Which Stock Is the Better Value Option?
Is Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PRFZ
Inter Parfums (IPAR) Secures Roberto Cavalli Fragrance License
by Zacks Equity Research
Inter Parfums (IPAR) remains committed to innovation and meeting the evolving demands of fragrance enthusiasts worldwide.
Coty (COTY) Focuses on Boosting Global Presence, Ups FY23 View
by Zacks Equity Research
Coty (COTY) is hosting its first investor event in Paris, wherein it is set to provide details regarding the financial performance, operating landscape and growth agenda. It is also raising guidance.
Hormel Foods (HRL) Exhibits Solid Prospects Despite Risks
by Zacks Equity Research
Hormel Foods (HRL) is poised to benefit from its business strength, strategic investments and acquisitions. However, supply-chain inefficiencies remain concerning.
Estee Lauder (EL) Gains From Emerging Market Presence Amid Risks
by Zacks Equity Research
Estee Lauder (EL) is poised to benefit from its online business, investments in new technology and digital experiences, as well as its strength in emerging markets. However, high operating expenses remain a concern.
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Clorox (CLX) Surpasses the Industry in a Year: Here's How
by Zacks Equity Research
Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.
Here's Why Procter & Gamble (PG) is an Attractive Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.
Watch These 4 Cosmetics Stocks as Industry Looks Radiant
by Zacks Equity Research
The Zacks Cosmetics industry players benefit from their focus on innovation and online strength amid favorable demand. Coty (COTY), el.f. Beauty (ELF), Inter Parfums (IPAR) and Helen of Troy (HELE) look well-placed.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Here's Why You Should Consider Investing in COTY Stock Now
by Zacks Equity Research
COTY is poised to benefit from its focus on six strategic pillars, strength across its businesses, acquisitions and cost management efforts.
This Top Consumer Staples Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why Is Coty (COTY) Down 0.3% Since Last Earnings Report?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.